An opportunity for improvement: iPLEDGE policy changes during the coronavirus pandemic.

Pathoulas, James T; Farah, Ronda S; Fiessinger, Lori; Mansh, Matthew

Pathoulas, James T; Farah, Ronda S; Fiessinger, Lori; Mansh, Matthew.

Pathoulas JT; University of Minnesota Medical School, Minneapolis, Minnesota, USA.
Farah RS; Department of Dermatology, University of Minnesota Medical School, Minneapolis, Minnesota, USA.
Fiessinger L; Department of Dermatology, University of Minnesota Medical School, Minneapolis, Minnesota, USA.
Mansh M; Department of Dermatology, University of Minnesota Medical School, Minneapolis, Minnesota, USA.

Dermatol Ther ; 33(6): e14411, 2020 Nov.

Article in English | MEDLINE | ID: covidwho-857859

Subject(s)

Abnormalities, Drug-Induced/prevention & control; COVID-19; Dermatologic Agents/adverse effects; Isotretinoin/adverse effects; Policy Making; Pregnancy Tests; Risk Management; Telemedicine; Teratogens; Abnormalities, Drug-Induced/etiology; Female; Humans; Pregnancy; Risk Assessment; Risk Factors; Urinalysis

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Policy Making / Pregnancy Tests / Risk Management / Teratogens / Abnormalities, Drug-Induced / Isotretinoin / Telemedicine / Dermatologic Agents / COVID-19 Type of study: Diagnostic study / Prognostic study Limits: Female / Humans / Pregnancy Language: English Journal: Dermatol Ther Journal subject: Dermatology Year: 2020 Document Type: Article Affiliation country: Dth.14411

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google